CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$473.68

Market cap

$7.45B

P/E Ratio

24.9

Dividend/share

$1.38

EPS

$19.02

Enterprise value

$7.5B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
CHE's gross profit is up by 18% year-on-year and by 4.4% since the previous quarter
The price to earnings (P/E) is 15% lower than the 5-year quarterly average of 29.7
Chemed's quick ratio has soared by 69% YoY but it has decreased by 26% from the previous quarter
The EPS has increased by 16% YoY but it has decreased by 8% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com
Peers: AMED LHCG SXT BCPC

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
15.73M
Market cap
$7.45B
Enterprise value
$7.5B
Valuations
Price to earnings (P/E)
24.9
Price to book (P/B)
8.68
Price to sales (P/S)
3.53
EV/EBIT
19.33
EV/EBITDA
16.78
EV/Sales
3.53
Earnings
Revenue
$2.12B
EBIT
$387.7M
EBITDA
$446.62M
Free cash flow
$283.32M
Per share
EPS
$19.02
Free cash flow per share
$17.9
Book value per share
$54.59
Revenue per share
$134.01
TBVPS
$43.72
Balance sheet
Total assets
$1.38B
Total liabilities
$513.02M
Debt
$135.53M
Equity
$870.77M
Working capital
$1.68M
Liquidity
Debt to equity
0.16
Current ratio
1.01
Quick ratio
0.81
Net debt/EBITDA
0.1
Margins
EBITDA margin
21.1%
Gross margin
35.6%
Net margin
14.3%
Operating margin
17.4%
Efficiency
Return on assets
21.5%
Return on equity
34.7%
Return on invested capital
94.6%
Return on capital employed
34.7%
Return on sales
18.3%
Dividend
Dividend yield
0.29%
DPS
$1.38
Payout ratio
7.3%

CHE stock price

How has the Chemed stock price performed over time
Intraday
-0.93%
1 week
-0.37%
1 month
3.77%
1 year
-1.1%
YTD
-11.06%
QTD
-0.17%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.12B
Gross profit
$755.95M
Operating income
$369.7M
Net income
$303.4M
Gross margin
35.6%
Net margin
14.3%
Chemed's operating income has increased by 18% YoY but it has decreased by 5% from the previous quarter
CHE's gross profit is up by 18% year-on-year and by 4.4% since the previous quarter
The net income has grown by 16% year-on-year but it has declined by 8% since the previous quarter
Chemed's gross margin has increased by 12% YoY and by 2.9% from the previous quarter

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
24.9
P/B
8.68
P/S
3.53
EV/EBIT
19.33
EV/EBITDA
16.78
EV/Sales
3.53
The EPS has increased by 16% YoY but it has decreased by 8% from the previous quarter
The price to earnings (P/E) is 15% lower than the 5-year quarterly average of 29.7
Chemed's equity has increased by 16% YoY but it has decreased by 6% from the previous quarter
The P/B is 7% more than the 5-year quarterly average of 8.2
CHE's P/S is 23% above its 5-year quarterly average of 2.9 but 3.5% below its last 4 quarters average of 3.7
The revenue rose by 5% year-on-year

Efficiency

How efficient is Chemed business performance
The company's return on invested capital rose by 42% YoY but it fell by 10% QoQ
The ROS has increased by 16% YoY but it has decreased by 7% from the previous quarter
The ROE has contracted by 11% from the previous quarter and by 6% YoY
The ROA has declined by 9% since the previous quarter but it rose by 3.9% year-on-year

Dividends

What is CHE's dividend history
DPS
$1.38
Dividend yield
0.29%
Payout ratio
7.3%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 170% higher than its total liabilities
CHE's current ratio has soared by 71% YoY but it is down by 16% from the previous quarter
Chemed's quick ratio has soared by 69% YoY but it has decreased by 26% from the previous quarter
The debt is 84% smaller than the equity
CHE's debt to equity is down by 16% year-on-year but it is up by 7% since the previous quarter
Chemed's equity has increased by 16% YoY but it has decreased by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.